Neonatal Intensive Care Respiratory Devices Market Report 2026

The neonatal intensive care respiratory devices market size has grown rapidly in recent years. It will grow from $2.61 billion in 2025 to $2.89 billion in 2026 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to increasing incidence of preterm births, rising demand for advanced neonatal respiratory support, growing awareness of neonatal health complications, increasing adoption of ventilators in NICUs, rising number of neonatal intensive care units globally, growing use of non-invasive respiratory assistance, increasing investments in neonatal healthcare infrastructure, rising prevalence of neonatal respiratory disorders, growing availability of technologically advanced devices, increasing focus on improving neonatal survival rates.

The neonatal intensive care respiratory devices market size is expected to see rapid growth in the next few years. It will grow to $4.35 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing adoption of non-invasive respiratory technologies, rising demand for advanced NICU respiratory equipment, growing investments in neonatal critical care, increasing need for improved neonatal survival outcomes, rising awareness of preterm birth complications, growing healthcare spending on infant care, increasing use of automated respiratory monitoring, rising technological enhancements in neonatal devices, growing focus on early intervention respiratory support, increasing preference for safe and effective ventilation systems. Major trends in the forecast period include advancement in non-invasive neonatal ventilation, advancement in compact and portable respiratory devices, advancement in automated respiratory monitoring, innovation in neonatal oxygen delivery systems, innovation in ai-assisted ventilation tools, innovation in high-flow nasal cannula devices, integration of smart monitoring sensors, integration with real-time nicu data platforms, integration of tele-neonatology capabilities, advancement in hybrid ventilation technologies.

The increasing prevalence of neonatal respiratory complications is expected to drive the growth of the neonatal intensive care respiratory devices market in the coming years. Neonatal respiratory complications, such as respiratory distress syndrome and transient tachypnea, impair lung function shortly after birth and are a leading cause of neonatal morbidity and mortality. The rise in these complications is linked to higher rates of prematurity and greater medical complexity at birth, resulting in more infants requiring intensive respiratory support. Neonatal intensive care respiratory devices assist in managing these complications by providing assisted ventilation, precise oxygen delivery, and continuous respiratory monitoring, helping clinicians stabilize newborns and improve survival outcomes. For example, in October 2024, according to the Royal College of Paediatrics and Child Health, a UK-based professional medical body, the proportion of babies experiencing bronchopulmonary dysplasia or death varied across regions, ranging from 32.6% in the East of England to 46.8% in the Northern Operational Delivery Network, with individual neonatal units reporting rates between 0% and 61.7% for units with at least 10 eligible babies. Therefore, the growing prevalence of neonatal respiratory complications is fueling the market for neonatal intensive care respiratory devices.

The rising investment in neonatal care equipment is also expected to propel the growth of the neonatal intensive care respiratory devices market. Investment in neonatal care equipment involves allocating financial resources by governments and public health systems to acquire and upgrade medical devices and infrastructure dedicated to newborn health services, including neonatal intensive care devices. This trend is driven by the increasing need for precise thermal regulation, as preterm and low-birth-weight infants often cannot maintain stable body temperature independently. Enhanced investment supports the development and adoption of advanced neonatal intensive care respiratory devices that deliver reliable, precise respiratory support to premature and critically ill infants, improving survival rates, reducing complications, and promoting better overall neonatal outcomes. For instance, in November 2025, according to the OECD, a Paris-based international economic organization, average annual capital expenditure on health across member countries rose from 0.60% of GDP in 2024 to 0.62% of GDP in 2025, with a notable share allocated to medical equipment, reflecting a year-on-year increase in public sector investment in health infrastructure and neonatal care devices. Therefore, rising investment in neonatal care equipment is contributing to the growth of the neonatal intensive care respiratory devices market.

In January 2024, Inspiration Healthcare Group plc, a UK-based provider of neonatal and critical care medical technology, acquired Airon Corporation for approximately $2.5 million. Through this acquisition, Inspiration Healthcare expanded its global presence and strengthened its neonatal respiratory device portfolio by incorporating Airon’s pneumatic ventilators and CPAP systems, enhancing its commercial platform for neonatal respiratory support, particularly in the US and North American markets. Airon Corporation is a US-based manufacturer of specialized pneumatic oxygen-powered life support ventilators and continuous positive airway pressure (CPAP) systems for neonatal and intensive care applications.

Major companies operating in the neonatal intensive care respiratory devices market are Medtronic plc, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Becton, Dickinson and Company (BD), ResMed Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Smiths Group plc, Teleflex Incorporated, Masimo Corporation, Fisher & Paykel Healthcare Limited, Comen Medical, Hamilton Medical AG, GaleMed Corporation, Heyer Medical AG, Inspiration Healthcare Group plc, Mercury Medical, Trudell Medical International Co., Atom Medical International Co. Ltd., Airon Corporation, Lowenstein Medical Technology GmbH.

North America was the largest region in the neonatal intensive care respiratory devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal intensive care respiratory devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neonatal intensive care respiratory devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the neonatal intensive care respiratory devices market by increasing costs of imported sensors, microcontrollers, ventilator components, humidification systems, and monitoring electronics. hospitals and neonatal clinics in north america and europe are most affected due to reliance on imported high-precision medical components, while asia-pacific faces cost pressures on device manufacturing and exports. these tariffs are increasing procurement costs and slowing replacement cycles. however, they are also encouraging localized medical device manufacturing, regional supply chain development, and innovation in cost-optimized neonatal respiratory solutions.

Neonatal intensive care respiratory devices are specialized medical instruments designed to assist breathing in newborns experiencing respiratory distress or underdeveloped lung function. These devices deliver oxygen, regulate airflow, and provide assisted ventilation to stabilize neonatal respiration. They are critical for maintaining proper respiratory function in fragile newborns requiring intensive medical care.

The key product types of neonatal intensive care respiratory devices include ventilators, CPAP devices, oxygen delivery systems, inhalers, humidifiers, and others. Ventilators assist or replace natural breathing in neonates with impaired lung function. Devices are used across invasive, non-invasive, and hybrid systems, designed for extremely preterm to full-term infants, used in hospitals, neonatal clinics, ambulatory centers, and others.

The neonatal intensive care respiratory devices market consists of sales of ventilators, continuous positive airway pressure (CPAP) devices, oxygen delivery systems, respiratory monitors, and humidification systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.